Project Recommendation

Carbosulfan Sodium injection

Time: 2022-02-11

Project Recommendation
Information on the reference formulation	Common name	Carbosulfan Sodium injection
	Trade Name	Adona
	English Name	Carbosulfan Sodium injection
	Dosage form	Injection
	Specification	25mg/5ml,50mg/10ml
	Holder	ニプロESファーマ株式会社
	Country of marketing	Japan
	Features	【Pharmacology and Toxicology】 This product can reduce capillary permeability, enhance the retraction of capillary rupture, increase capillary resistance to injury, and is commonly used for a variety of bleeding caused by increased capillary permeability.
	Indications	It is used for bleeding disorders of the urinary system, upper gastrointestinal tract, respiratory tract and obstetrics and gynaecology. It is also used for the prevention and treatment of surgical bleeding.
Generic drug registration classification		Classified 3 of Chemicals
Project advantages		Market advantages: There are no new approved manufacturers in China according to the consistency evaluation requirements of injectables. Compared to other similar drugs, the advantages of this variety are: high stability and easy storage; fast-acting and highly effective. The product can be used in combination with a variety of drugs. Shanghai Baolong has experience in developing mature API and injection research.